Monday, May 28, 2012
Advertisement

News: May 28, 2012

FDA Thinks Shortage of Cancer Drug for Kids Can Be Averted
TUESDAY, Feb. 14 (HealthDay News) -- The U.S. Food and Drug Administration said Tuesday that it was cautiously optimistic that a feared shortage of a life-saving drug used to treat a form of childhood leukemia will be averted. The drug, methotrexa...
DNA Damage From Chemo May Help Spur Leukemia's Return
THURSDAY, Jan. 12 (HealthDay News) -- The chemotherapy used to treat a form of adult leukemia sets a trap that can result in the return of the disease within years, a new study suggests. The finding confirms the suspicions of specialists who thoug...
Leukemia Survivor Credits Her Life to Tiny Blood Donors
FRIDAY, Oct. 7 (HealthDay News) -- Jennifer Jones Austin works as a lawyer and child advocate in Brooklyn, N.Y., devoting her talents to protecting at-risk children. So it may be fitting that in Austin's own hour of need, her life was saved by don...
Chronic Tylenol Use May Be Linked to Blood Cancer, Study Suggests
TUESDAY, May 10 (HealthDay News) -- Those who take acetaminophen -- best known as Tylenol -- regularly for some time might be putting themselves at an increased risk for developing certain blood cancers, University of Washington researchers report...
Low Vitamin D Linked to Deterioration in Certain Leukemia Patients
FRIDAY, Nov. 12 (HealthDay News) -- Patients with a certain type of leukemia who had insufficient vitamin D levels when their cancer was diagnosed saw their disease progress much faster and were two times more likely to die than those with adequat...
Some With Once-Deadly Leukemia Can Take a Break From Gleevec
TUESDAY, Oct. 19 (HealthDay News) -- A small group of people with chronic myeloid leukemia (CML) who decided to stop taking the cancer drug Gleevec (imatinib) have remained cancer-free two years later, French researchers report. The study, publish...
3 or More X-Rays May Raise Leukemia Risk Among Kids: Study
FRIDAY, Oct. 8 (HealthDay News) -- Researchers report that exposure to three or more X-rays in childhood may double the odds that a child will develop a form of leukemia, although the overall risk remains small. The study authors aren't calling fo...
Tasigna Approval Widened to Include Early Stages of Rare Leukemia
FRIDAY, June 18 (HealthDay News) -- The anti-cancer drug Tasigna (nilotinib) has received new approval from the U.S. Food and Drug Administration to include people in the early stages of a rare blood cancer called Philadelphia chromosome positive ...
Green Tea Compound Slowed Chronic Lymphocytic Leukemia
MONDAY, June 7 (HealthDay News) -- A key component of green tea has shown promise as a non-toxic treatment for chronic lymphocytic leukemia (CLL). Researchers at the Mayo Clinic are now in the second phase of trials with early-stage, asymptomatic ...
Newer Drugs Beat Gleevec in Head-to-Head Trials
SATURDAY, June 5 (HealthDay News) -- Two new drugs, dasatinib (Sprycel) and nilotinib (Tasigna), appear better than imatinib (Gleevec) in treating patients with newly diagnosed chronic myeloid leukemia and should be considered as first-line treatm...
Genetic Pattern May Predict Leukemia Relapse
THURSDAY, May 13 (HealthDay News) -- Researchers have linked a genetic pattern to the likelihood that patients with a severe form of childhood leukemia will relapse. The finding could lead doctors to screen for the pattern and treat those who have...
Drinking While Pregnant Tied to Rare Leukemia in Offspring
THURSDAY, May 6 (HealthDay News) -- Pregnant woman may have another reason to avoid drinking, with a new study finding that alcohol use during pregnancy ups the risk for a rare blood cancer in children. The research, by French scientists, found th...
Rituxan Approved for Chronic Lymphocytic Leukemia
FRIDAY, Feb. 19 (HealthDay News) -- Rituxan (rituximab) has been approved by the U.S. Food and Drug Administration to treat a slowly progressing form of blood and bone marrow cancer known as chronic lymphocytic leukemia (CLL), the agency said in a...
High Rates of Childhood Leukemia Seen in Iraq Province
THURSDAY, Feb. 18 (HealthDay News) -- Childhood leukemia rates more than doubled in a southern Iraq province over a 15-year period, although the exact cause for the increase is unclear, researchers say. Possible reasons why so many kids in the pro...
Stem Cell, Bone Marrow Transplants Both Benefit Leukemia Patients
MONDAY, Feb. 1 (HealthDay News) -- Long-term survival rates are similar for leukemia patients who've had either peripheral blood stem cell (PBSC) or bone marrow transplants, a new European study says. The study began with 329 leukemia patients who...
Study Suggests Way to 'Mop Up' Leukemia Cells
FRIDAY, Jan. 8 (HealthDay News) -- Preliminary research suggests that a vaccine could help reduce the risk of a relapse in some people who take the drug Gleevec to treat chronic myeloid leukemia. "Should this vaccine approach prove to be successfu...
Leukemia Drug May Help Some Ovarian Cancer Patients
THURSDAY, Nov. 12 (HealthDay News) -- A drug for people with a form of leukemia holds promise as a possible treatment for ovarian cancer, new research suggests. The drug dasatinib (Sprycel) is used to treat chronic myeloid leukemia. Researchers at...
Arzerra Approved for Chronic Lymphocytic Leukemia
TUESDAY, Oct. 27 (HealthDay News) -- Arzerra (ofatumumab) has been approved by the U.S. Food and Drug Administration to treat chronic lymphocytic leukemia (CLL), a cancer of the blood and bone marrow. The drug, produced by London-based GlaxoSmithK...
Leukemia Drug in High Dose Helps Survival
WEDNESDAY, Sept. 23 (HealthDay News) -- Patients with acute myeloid leukemia (AML), take note: A new standard of care is emerging -- at least for those younger than 50, or between 60 and 65. That's the take-home message of a pair of studies publis...
Leukemia Cells May Hide in Fat Tissue
TUESDAY, Sept. 22 (HealthDay News) -- Leukemia cells can hide in fat tissue to evade chemotherapy, which may explain why obese children with leukemia are more likely to develop chemotherapy resistance and have higher relapse rates, researchers say...
Treating Childhood Leukemia With Fewer Side Effects
THURSDAY, Sept. 10 (HealthDay News) -- Adding the corticosteroid dexamethasone to the treatment regimen of children with acute lymphoblastic leukemia improves survival rates and reduces the incidence of the cancer recurring, a new Dutch study show...
Steady Improvements Seen for Young Blood Cancer Patients
THURSDAY, Aug. 27 (HealthDay News) -- American teens and young adults newly diagnosed with blood-related cancers now live longer than they did in the 1980s, new research has found. Researchers analyzed data from the Surveillance, Epidemiology and ...
Exercise May Help in Leukemia Recovery
THURSDAY, Aug. 13 (HealthDay News) -- Exercise helps improve symptoms of fatigue and depression experienced by leukemia patients who are undergoing treatment, a new study shows. It included 10 people who did individualized exercise sessions while ...
Genome of Leukemia Patient Reveals Common Mutations
WEDNESDAY, Aug. 5 (HealthDay News) -- Decoding the genome of a man with acute myeloid leukemia (AML) revealed genetic mutations that may be common among other cancer patients. Scientists at the Washington University School of Medicine in St. Louis...
Molecule Helps Leukemia Cells Hide From Immune System
THURSDAY, July 23 (HealthDay News) -- Leukemia stem cells cleverly cloak themselves to avoid detection by a person's immune system, according to a pair of studies by researchers at Stanford University Medical School. The cells co-opt a protective ...
New Drug Could Work Against Leukemia
THURSDAY, July 2 (HealthDay News) -- A new targeted therapy shows promise in treating acute myeloid leukemia, a highly treatment-resistant blood cancer, according to a new study. Researchers created an antibody (7G3) that recognizes and binds to a...
For Kids With Leukemia, Radiation May Be Safe to Skip
WEDNESDAY, June 24 (HealthDay News) -- Radiation to the brain isn't necessary for most children with newly diagnosed acute lymphoblastic leukemia, new research has found. In fact, doctors from St. Jude Children's Research Hospital found that child...
Taking Aim at Relapse of Leukemia in Kids
WEDNESDAY, June 17 (HealthDay News) -- Scientists have identified molecules that enable tumor cells to invade the nervous system of patients with a blood-borne childhood cancer, a finding that may lead to the development of drugs that block these ...
Donor Stem-Cell Transplant Best For Acute Myeloid Leukemia
TUESDAY, June 9 (HealthDay News) -- For most patients with acute myeloid leukemia (AML) who come out of remission, donor stem cells appear to offer the best shot at survival, a new analysis shows. AML is the most common form of acute leukemia, str...
Leukemia Risk From MS Drug May Be Up
THURSDAY, April 30 (HealthDay News) -- The risk of developing leukemia from a drug used to treat rapidly-progressing multiple sclerosis is three times higher than previously reported, new research shows. Italian researchers found that for every 1,...
Gene Studies Reveal Cancer's Secrets
TUESDAY, April 21 (HealthDay News) -- A close look at a tumor's or patient's genetics can provide important, potentially lifesaving clues to preventing and treating cancer. So say scientists who outlined their research Tuesday in five presentation...
Signs of Leukemia Show Up Years Before Diagnosis
WEDNESDAY, Feb. 11 (HealthDay News) -- Abnormal blood cells can appear in the blood years before a person is diagnosed with chronic lymphocytic leukemia (CCL), U.S. researchers say. They added that this finding may help improve understanding of ce...
In Kids, Genes May Affect Leukemia Treatment
TUESDAY, Jan. 27 (HealthDay News) -- Genetic variations appear to affect the way children respond to treatment for lymphoblastic leukemia, researchers report. Although about 80 percent of children suffering from this type of blood and bone marrow ...
Hard-to-Treat Leukemia Cell Subtype Identified
WEDNESDAY, Jan. 14 (HealthDay News) -- Researchers say they may have identified a subtype of T-lymphoblastic leukemia (T-ALL) in children that does not respond to standard intensive chemotherapy. Approximately 20 percent of children with T-ALL fai...
Childhood Leukemia Subtype Resists Treatment
FRIDAY, Jan. 9 (HealthDay News) -- Researchers say they have identified a rare subtype of a childhood leukemia that does not respond well to treatment. Those with the subtype of acute lymphoblastic leukemia (ALL) have a BCR-ABL1 fusion gene. In th...
Gene Governs Response to Leukemia Chemotherapy
WEDNESDAY, Jan. 7 (HealthDay News) -- A mutation in leukemia cells predicts which children with acute lymphoblastic leukemia are more likely to relapse. The discovery, reported online Jan. 7 in the New England Journal of Medicine, might lead to te...
Grape Seed Extract Kills Leukemia Cells in Lab
WEDNESDAY, Dec. 31 (HealthDay News) -- More than three-quarters of laboratory leukemia cells exposed to an extract from grape seeds died within 24 hours, effectively killing themselves while leaving other cells unharmed, a new study shows. Univers...
Healthline Tools
3D Body Maps
Advertisement
Copyright © 2005 - 2012 Healthline Networks, Inc. All rights reserved.
Healthline is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations. more details